Search for: "Novartis AG"
Results 161 - 180
of 440
Sort by Relevance
|
Sort by Date
23 Feb 2015, 2:55 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
22 Feb 2015, 9:59 pm
Pfizer, Inc. 2:15-cv-01283; filed February 18, 2015 in the District Court of New Jersey • Plaintiffs: Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG • Defendant: Pfizer, Inc. [read post]
16 Feb 2015, 1:44 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
15 Feb 2015, 9:43 pm
Novartis AG et al. v. [read post]
9 Feb 2015, 1:15 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
8 Feb 2015, 9:59 pm
Roxane Laboratories Inc. 1:15-cv-00128; filed February 5, 2015 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
2 Feb 2015, 2:20 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) reports on the Hague Court of Appeal’s summary ruling in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
29 Jan 2015, 10:31 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) the following news:Rutger KleemansOn 27 January the Hague Court of Appeal (judges Kalden, Brinkman and Van Nispen) ruled in summary proceedings in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
23 Jan 2015, 4:58 am
The company — dRx Capital AG — will invest up to $100 million to support early stage digital health companies. [read post]
10 Jan 2015, 3:02 am
Some workers have hearing losses associated with age and fail to address the issue and create a potential safety concern in the workplace. [read post]
4 Jan 2015, 9:21 pm
Roxane Laboratories Inc. 1:14-cv-01508; filed December 23, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
28 Dec 2014, 9:49 pm
Par Pharmaceutical Inc. 1:14-cv-01494; filed December 18 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Par Pharmaceutical Inc. [read post]
24 Dec 2014, 5:00 am
Novartis Pharmaceutical Corp., 767 F.3d 526 (6th Cir. 2014). [read post]
21 Dec 2014, 11:04 pm
The rejection was largely a result […] The post Novartis AG v. [read post]
15 Dec 2014, 7:25 am
Last week was the busiest in the IPKat's history, with a total of 29 blogposts. [read post]
9 Dec 2014, 3:50 am
He cited the VODKAT and Rihanna cases [Katposts here and here] which appear to suggest that case law has not actually moved very far from its original position.Next to speak was Myrtha Hurtado Rivas (Novartis AG), who gave a strategic overview of the trade mark v unfair competition position from the standpoint of a business that had to make decisions as to how -- and where -- to enforce its rights and protect its interests in the Europe of today -- and beyond. [read post]
21 Oct 2014, 12:00 am
In Novartis AG v Generics (UK) Limited (t/a Mylan) [2012] EWCA Civ1623, discussed by the IPKat (see here) the Court of Appeal had to review the decision of Floyd J (here) in assessing inventive step where the compound went through several steps during research and development. [read post]
5 Sep 2014, 12:31 am
A serogroup B vaccine (Bexsero, Novartis) was licensed in Europe, Australia, and Canada in 2013 and has received a "breakthrough therapy" designation from the Food and Drug Administration.Employers should be familiar with laboratory biosafety recommendations and ensure that a laboratory biosafety program is in place. [read post]
30 Aug 2014, 5:03 am
In PARADIGM-HF the average age was 64 years old, considerably younger than the typical patient with heart failure. [read post]
25 Aug 2014, 9:35 am
Novartis Pharm. [read post]
